Shareholder Director Nominations


On March 4, 2021, the board of directors (the “Board”) of Allena Pharmaceuticals, Inc. (the “Company”) established June 3, 2021,
as the date for the Company’s 2021 Annual Meeting of Stockholders (the “Annual Meeting”) and set April 5, 2021, as the record date for the Annual Meeting. Due to the fact that the date of the Annual Meeting has been changed by
more than thirty (30) days from the anniversary date of the 2020 Annual Meeting of Stockholders, the Company is providing the due date for submission of any qualified stockholder proposal or qualified stockholder nominations.


In accordance with Rule

14a-5(f)

and Rule

14a-8(e)

under the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), and the Company’s amended and restated bylaws (the “Bylaws”), the deadline for receipt of stockholder proposals or nominations for inclusion in the Company’s proxy
statement for the Annual Meeting pursuant to Rule

14a-8

will be no later than 5:00 p.m., Eastern Time, March 15, 2021, or the tenth (10

th

) day
following this public announcement of the meeting date. Stockholder proposals must comply with all of the applicable requirements set forth in the rules and regulations of the Securities and Exchange Commission, including Rule

14a-8

under the Exchange Act and the Bylaws. Stockholder proposals and director nominations should be addressed to our Secretary, c/o Allena Pharmaceuticals, Inc., One Newton Executive Park, Suite 202, Newton, MA
02462.






SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.

 










Date: March 5, 2021


  


Allena Pharmaceuticals, Inc.








  


By:


 


/s/ Richard D. Katz




  



 


Richard D. Katz, MD




  



 


Chief Financial Officer





makes a similar move, sign up!

Other recent filings from the company include the following:

Statement of acquisition of beneficial ownership by individuals - Jan. 25, 2022
Allena Pharmaceuticals Provides Clinical And Corporate Update ALLN-346, - Jan. 4, 2022

Auto Refresh

Feedback